Antibiotic Developments Insights
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
Antimicrobial resistance a leading cause of global deaths, study shows
Antimicrobial resistance (AMR) has been found to be a leading cause of death worldwide in a study published in The Lancet. Read more
20 Jan 2022
BioVersys receives funding to develop new class of antibiotics to treat multidrug-resistant bacterial infections
Switzerland-based pharmaceutical company BioVersys has been awarded up to $4.35 million in funding to develop a new class of antibiotics for its work in developing a new class of antibiotics. Read more
7 Jun 2021
Sponsored Content
The challenges of sustainability
EPM sits down with Merck’s Jeffrey Whitford to find out about where the company is up to in terms of its sustainability initiatives. Read more
12 May 2022
Top three approaches for pharma communication
Pavel Klymenko, head of omnichannel excellence at Viseven, discusses his opinion on the best approaches to communication in pharma. Read more
6 May 2022
Research finds general public are positive about gene therapies
Polling conducted across six European countries, with over 6,000 respondents, finds high levels of excitement for gene therapy and medical innovation, particularly for the treatment of rare diseases. Read more
27 Apr 2022
Social media could be key to vaccinating older generation, study shows
Social media advertising could be a cost-effective of way of encouraging older people in deprived communities to get vaccinated, new research shows. Read more
19 Apr 2022
Perspective on Pharma: How powerful AI is turning intervention into prevention
We know disease exists, where it comes from and how it evolves - but we don’t yet know ahead of time when something changes to mark the start of a new disease, a new variant or just an increase in transmission. Read more
13 Apr 2022
Editor's desk: Reflections
In his last editor's desk, Reece Armstrong reflects on his time at the helm of European Pharmaceutical Manufacturer. Read more
5 Apr 2022
